{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:13:16Z","timestamp":1793812396319,"version":"4.6.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-026-01964-2","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:57:52Z","timestamp":1769695072000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Glymphatic dysfunction links vascular pathology to Alzheimer\u2019s biomarkers and cognitive decline"],"prefix":"10.1186","volume":"18","author":[{"given":"Sung Hoon","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seongmi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heejin","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Hye","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyemin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daeun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihwan","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Pyo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duk L.","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrick","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Gonzalez-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Ashton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa A.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Duering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Beom","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eung Yeop","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beomseok","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Won","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"issue":"10284","key":"1964_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer\u2019s disease. Lancet. 2021;397(10284):1577\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(20)32205-4. [published Online First: 20210302].","journal-title":"Lancet"},{"issue":"4","key":"1964_CR2","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.06.002","volume":"23","author":"Y Noh","year":"2014","unstructured":"Noh Y, Lee Y, Seo SW, et al. A new classification system for ischemia using a combination of deep and periventricular white matter hyperintensities. J Stroke Cerebrovasc Dis. 2014;23(4):636\u201342. [published Online First: 20130716].","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"7","key":"1964_CR3","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1093\/brain\/awx047","volume":"140","author":"A Charidimou","year":"2017","unstructured":"Charidimou A, Boulouis G, Gurol ME, et al. Emerging concepts in sporadic cerebral amyloid angiopathy. Brain. 2017;140(7):1829\u201350. https:\/\/doi.org\/10.1093\/brain\/awx047.","journal-title":"Brain"},{"issue":"1","key":"1964_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3233\/JAD-221207","volume":"93","author":"Y Sun","year":"2023","unstructured":"Sun Y, Hu HY, Hu H, et al. Cerebral small vessel disease burden predicts neurodegeneration and clinical progression in prodromal alzheimer\u2019s disease. J Alzheimers Dis. 2023;93(1):283\u201394. https:\/\/doi.org\/10.3233\/JAD-221207.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1964_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13024-023-00640-5","volume":"18","author":"Y Inoue","year":"2023","unstructured":"Inoue Y, Shue F, Bu G, et al. Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and alzheimer\u2019s disease. Mol Neurodegener. 2023;18(1):46. https:\/\/doi.org\/10.1186\/s13024-023-00640-5. [published Online First: 20230711].","journal-title":"Mol Neurodegener"},{"issue":"8","key":"1964_CR6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist S, Janelidze S, Quiroz YT, et al. Discriminative accuracy of plasma Phospho-tau217 for alzheimer disease vs other neurodegenerative disorders. JAMA. 2020;324(8):772\u201381. https:\/\/doi.org\/10.1001\/jama.2020.12134.","journal-title":"JAMA"},{"issue":"1","key":"1964_CR7","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13195-020-00682-7","volume":"12","author":"IMW Verberk","year":"2020","unstructured":"Verberk IMW, Thijssen E, Koelewijn J, et al. Combination of plasma amyloid beta((1\u201342\/1\u201340)) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology. Alzheimers Res Ther. 2020;12(1):118. https:\/\/doi.org\/10.1186\/s13195-020-00682-7. [published Online First: 20200928].","journal-title":"Alzheimers Res Ther"},{"issue":"6","key":"1964_CR8","doi-asserted-by":"publisher","first-page":"e14022","DOI":"10.15252\/emmm.202114022","volume":"13","author":"N Mattsson-Carlgren","year":"2021","unstructured":"Mattsson-Carlgren N, Janelidze S, Bateman RJ, et al. Soluble P-tau217 reflects amyloid and Tau pathology and mediates the association of amyloid with Tau. EMBO Mol Med. 2021;13(6):e14022. https:\/\/doi.org\/10.15252\/emmm.202114022. [published Online First: 20210505].","journal-title":"EMBO Mol Med"},{"issue":"12","key":"1964_CR9","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","volume":"78","author":"AL Benedet","year":"2021","unstructured":"Benedet AL, Mil\u00e0-Alom\u00e0 M, Vrillon A, et al. Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the alzheimer disease continuum. JAMA Neurol. 2021;78(12):1471\u201383. https:\/\/doi.org\/10.1001\/jamaneurol.2021.3671. [published Online First: 2021\/10\/19].","journal-title":"JAMA Neurol"},{"issue":"5","key":"1964_CR10","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","volume":"74","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, Andreasson U, Zetterberg H, et al. Association of plasma neurofilament light with neurodegeneration in patients with alzheimer disease. JAMA Neurol. 2017;74(5):557\u201366. https:\/\/doi.org\/10.1001\/jamaneurol.2016.6117. [published Online First: 2017\/03\/28].","journal-title":"JAMA Neurol"},{"issue":"5","key":"1964_CR11","doi-asserted-by":"publisher","first-page":"e258842","DOI":"10.1001\/jamanetworkopen.2025.8842","volume":"8","author":"SH Kang","year":"2025","unstructured":"Kang SH, Lee EH, Kim YJ, et al. Cerebral amyloid angiopathy and downstream alzheimer disease plasma biomarkers. JAMA Netw Open. 2025;8(5):e258842. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.8842. [published Online First: 20250501].","journal-title":"JAMA Netw Open"},{"issue":"3","key":"1964_CR12","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3233\/JAD-161139","volume":"57","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, Cho H, Werring DJ, et al. 18F-AV-1451 PET imaging in three patients with probable cerebral amyloid angiopathy. J Alzheimers Dis. 2017;57(3):711\u201316. https:\/\/doi.org\/10.3233\/JAD-161139.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1964_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.molmed.2019.11.008","volume":"26","author":"BC Reeves","year":"2020","unstructured":"Reeves BC, Karimy JK, Kundishora AJ, et al. Glymphatic system impairment in alzheimer\u2019s disease and idiopathic normal pressure hydrocephalus. Trends Mol Med. 2020;26(3):285\u201395. [published Online First: 20200118].","journal-title":"Trends Mol Med"},{"key":"1964_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1146\/annurev-pathol-051217-111018","volume":"13","author":"BA Plog","year":"2018","unstructured":"Plog BA, Nedergaard M. The glymphatic system in central nervous system health and disease: Past, Present, and future. Annu Rev Pathol. 2018;13:379\u201394. https:\/\/doi.org\/10.1146\/annurev-pathol-051217-111018.","journal-title":"Annu Rev Pathol"},{"issue":"8","key":"1964_CR15","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1093\/brain\/awaa179","volume":"143","author":"IF Harrison","year":"2020","unstructured":"Harrison IF, Ismail O, Machhada A, et al. Impaired glymphatic function and clearance of Tau in an alzheimer\u2019s disease model. Brain. 2020;143(8):2576\u201393. https:\/\/doi.org\/10.1093\/brain\/awaa179.","journal-title":"Brain"},{"issue":"4","key":"1964_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s11604-017-0617-z","volume":"35","author":"T Taoka","year":"2017","unstructured":"Taoka T, Masutani Y, Kawai H, et al. Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in alzheimer\u2019s disease cases. Jpn J Radiol. 2017;35(4):172\u201378. https:\/\/doi.org\/10.1007\/s11604-017-0617-z. [published Online First: 20170214].","journal-title":"Jpn J Radiol"},{"issue":"5","key":"1964_CR17","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1002\/alz.13789","volume":"20","author":"SY Huang","year":"2024","unstructured":"Huang SY, Zhang YR, Guo Y, et al. Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in alzheimer\u2019s disease. Alzheimers Dement. 2024;20(5):3251\u201369. https:\/\/doi.org\/10.1002\/alz.13789. [published Online First: 20240319].","journal-title":"Alzheimers Dement"},{"issue":"9","key":"1964_CR18","doi-asserted-by":"publisher","first-page":"e209306","DOI":"10.1212\/WNL.0000000000209306","volume":"102","author":"H Li","year":"2024","unstructured":"Li H, Jacob MA, Cai M, et al. Perivascular Spaces, diffusivity along perivascular Spaces, and free water in cerebral small vessel disease. Neurology. 2024;102(9):e209306. https:\/\/doi.org\/10.1212\/WNL.0000000000209306. [published Online First: 20240416].","journal-title":"Neurology"},{"issue":"2","key":"1964_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1037\/1040-3590.3.2.168","volume":"3","author":"KJ Christensen","year":"1991","unstructured":"Christensen KJ, Multhaup KS, Nordstrom S, et al. A cognitive battery for dementia: development and measurement characteristics. Psychol Assessment: J Consulting Clin Psychol. 1991;3(2):168\u201374. https:\/\/doi.org\/10.1037\/1040-3590.3.2.168.","journal-title":"Psychol Assessment: J Consulting Clin Psychol"},{"issue":"23","key":"1964_CR20","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1056\/NEJMcp0910237","volume":"364","author":"RC Petersen","year":"2011","unstructured":"Petersen RC. Clinical practice. Mild cognitive impairment. N Engl J Med. 2011;364(23):2227\u201334 https:\/\/doi.org\/10.1056\/NEJMcp0910237. [published Online First: 2011\/06\/10].","journal-title":"N Engl J Med"},{"issue":"2","key":"1964_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3988\/jcn.2020.16.2.202","volume":"16","author":"HJ Jeong","year":"2020","unstructured":"Jeong HJ, Lee H, Lee S-Y, et al. [18F]THK5351 PET imaging in patients with mild cognitive impairment. J Clin Neurol. 2020;16(2):202\u201314.","journal-title":"J Clin Neurol"},{"issue":"1","key":"1964_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe RA, Price JC, et al. The centiloid project: standardizing quantitative amyloid plaque Estimation by PET. Alzheimers Dement. 2015;11(1):1\u201315. https:\/\/doi.org\/10.1016\/j.jalz.2014.07.003. [published Online First: 2014\/12\/03]. .e1-4.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1964_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13195-020-00587-5","volume":"12","author":"S Amadoru","year":"2020","unstructured":"Amadoru S, Dor\u00e9 V, McLean CA, et al. Comparison of amyloid PET measured in centiloid units with neuropathological findings in alzheimer\u2019s disease. Alzheimers Res Ther. 2020;12(1):22. https:\/\/doi.org\/10.1186\/s13195-020-00587-5. [published Online First: 2020\/03\/07].","journal-title":"Alzheimers Res Ther"},{"issue":"18","key":"1964_CR24","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun MA, Lo AC, Duggan Evans C, et al. Donanemab in early alzheimer\u2019s disease. N Engl J Med. 2021;384(18):1691\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa2100708. [published Online First: 2021\/03\/16].","journal-title":"N Engl J Med"},{"issue":"4","key":"1964_CR25","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/alz.12748","volume":"19","author":"MS Rafii","year":"2023","unstructured":"Rafii MS, Sperling RA, Donohue MC, et al. The AHEAD 3\u201345 study: design of a prevention trial for alzheimer\u2019s disease. Alzheimers Dement. 2023;19(4):1227\u201333. https:\/\/doi.org\/10.1002\/alz.12748. [published Online First: 2022\/08\/17].","journal-title":"Alzheimers Dement"},{"issue":"12","key":"1964_CR26","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00259-017-3749-6","volume":"44","author":"CC Rowe","year":"2017","unstructured":"Rowe CC, Dore V, Jones G, et al. (18)F-Florbetaben PET beta-amyloid binding expressed in centiloids. Eur J Nucl Med Mol Imaging. 2017;44(12):2053\u201359. https:\/\/doi.org\/10.1007\/s00259-017-3749-6. [published Online First: 20170622].","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1964_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13550-018-0456-7","volume":"8","author":"MR Battle","year":"2018","unstructured":"Battle MR, Pillay LC, Lowe VJ, et al. Centiloid scaling for quantification of brain amyloid with [(18)F]flutemetamol using multiple processing methods. EJNMMI Res. 2018;8(1):107. https:\/\/doi.org\/10.1186\/s13550-018-0456-7. [published Online First: 20181205].","journal-title":"EJNMMI Res"},{"issue":"5","key":"1964_CR28","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1002\/mrm.26059","volume":"76","author":"J Veraart","year":"2016","unstructured":"Veraart J, Fieremans E, Novikov DS. Diffusion MRI noise mapping using random matrix theory. Magn Reson Med. 2016;76(5):1582\u201393. https:\/\/doi.org\/10.1002\/mrm.26059. [published Online First: 20151124].","journal-title":"Magn Reson Med"},{"issue":"3","key":"1964_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/hbm.10062","volume":"17","author":"SM Smith","year":"2002","unstructured":"Smith SM. Fast robust automated brain extraction. Hum Brain Mapp. 2002;17(3):143\u201355. https:\/\/doi.org\/10.1002\/hbm.10062.","journal-title":"Hum Brain Mapp"},{"key":"1964_CR30","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.neuroimage.2015.10.019","volume":"125","author":"JLR Andersson","year":"2016","unstructured":"Andersson JLR, Sotiropoulos SN. An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging. NeuroImage. 2016;125:1063\u201378. https:\/\/doi.org\/10.1016\/j.neuroimage.2015.10.019. [published Online First: 20151020].","journal-title":"NeuroImage"},{"key":"1964_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fninf.2014.00008","volume":"8","author":"E Garyfallidis","year":"2014","unstructured":"Garyfallidis E, Brett M, Amirbekian B, et al. Dipy, a library for the analysis of diffusion MRI data. Front Neuroinform. 2014;8:8. https:\/\/doi.org\/10.3389\/fninf.2014.00008. [published Online First: 2014\/03\/07].","journal-title":"Front Neuroinform"},{"key":"1964_CR32","doi-asserted-by":"publisher","first-page":"118257","DOI":"10.1016\/j.neuroimage.2021.118257","volume":"238","author":"W Zhang","year":"2021","unstructured":"Zhang W, Zhou Y, Wang J, et al. Glymphatic clearance function in patients with cerebral small vessel disease. NeuroImage. 2021;238:118257. https:\/\/doi.org\/10.1016\/j.neuroimage.2021.118257. [published Online First: 20210610].","journal-title":"NeuroImage"},{"issue":"7","key":"1964_CR33","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1474-4422(23)00131-X","volume":"22","author":"M Duering","year":"2023","unstructured":"Duering M, Biessels GJ, Brodtmann A, et al. Neuroimaging standards for research into small vessel disease-advances since 2013. Lancet Neurol. 2023;22(7):602\u201318. https:\/\/doi.org\/10.1016\/S1474-4422(23)00131-X. [published Online First: 20230523].","journal-title":"Lancet Neurol"},{"issue":"2","key":"1964_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S1474-4422(09)70013-4","volume":"8","author":"SM Greenberg","year":"2009","unstructured":"Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8(2):165\u201374. https:\/\/doi.org\/10.1016\/S1474-4422(09)70013-4. [published Online First: 2009\/01\/24].","journal-title":"Lancet Neurol"},{"issue":"21","key":"1964_CR35","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1212\/WNL.0b013e3181c34a7d","volume":"73","author":"SM Gregoire","year":"2009","unstructured":"Gregoire SM, Chaudhary UJ, Brown MM, et al. The microbleed anatomical rating scale (MARS): reliability of a tool to map brain microbleeds. Neurology. 2009;73(21):1759\u201366. https:\/\/doi.org\/10.1212\/WNL.0b013e3181c34a7d. [published Online First: 2009\/11\/26].","journal-title":"Neurology"},{"issue":"7","key":"1964_CR36","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1212\/WNL.0b013e3182a08f2c","volume":"81","author":"A Charidimou","year":"2013","unstructured":"Charidimou A, Jager RH, Fox Z, et al. Prevalence and mechanisms of cortical superficial siderosis in cerebral amyloid angiopathy. Neurology. 2013;81(7):626\u201332. https:\/\/doi.org\/10.1212\/WNL.0b013e3182a08f2c. [published Online First: 20130717].","journal-title":"Neurology"},{"issue":"3","key":"1964_CR37","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/STROKEAHA.109.564914","volume":"41","author":"FN Doubal","year":"2010","unstructured":"Doubal FN, MacLullich AM, Ferguson KJ, et al. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease. Stroke. 2010;41(3):450\u20134. https:\/\/doi.org\/10.1161\/STROKEAHA.109.564914. [published Online First: 20100107].","journal-title":"Stroke"},{"issue":"8","key":"1964_CR38","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822\u201338. https:\/\/doi.org\/10.1016\/S1474-4422(13)70124-8.","journal-title":"Lancet Neurol"},{"issue":"14","key":"1964_CR39","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1212\/wnl.0000000000000837","volume":"83","author":"J Staals","year":"2014","unstructured":"Staals J, Makin SD, Doubal FN, et al. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83(14):1228\u201334. https:\/\/doi.org\/10.1212\/wnl.0000000000000837. [published Online First: 2014\/08\/29].","journal-title":"Neurology"},{"issue":"8","key":"1964_CR40","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/jamaneurol.2016.0832","volume":"73","author":"A Charidimou","year":"2016","unstructured":"Charidimou A, Martinez-Ramirez S, Reijmer YD, et al. Total magnetic resonance imaging burden of small vessel disease in cerebral amyloid angiopathy: an imaging-Pathologic study of concept validation. JAMA Neurol. 2016;73(8):994\u20131001. https:\/\/doi.org\/10.1001\/jamaneurol.2016.0832. [published Online First: 2016\/07\/02].","journal-title":"JAMA Neurol"},{"key":"1964_CR41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jns.2017.07.015","volume":"380","author":"G Boulouis","year":"2017","unstructured":"Boulouis G, Charidimou A, Pasi M, et al. Hemorrhage recurrence risk factors in cerebral amyloid angiopathy: comparative analysis of the overall small vessel disease severity score versus individual neuroimaging markers. J Neurol Sci. 2017;380:64\u20137. [published Online First: 20170709].","journal-title":"J Neurol Sci"},{"key":"1964_CR42","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.3389\/fphar.2019.01656","volume":"10","author":"M Valenza","year":"2019","unstructured":"Valenza M, Facchinetti R, Steardo L, et al. Altered waste disposal system in aging and alzheimer\u2019s disease: focus on astrocytic Aquaporin-4. Front Pharmacol. 2019;10:1656. https:\/\/doi.org\/10.3389\/fphar.2019.01656. [published Online First: 20200129].","journal-title":"Front Pharmacol"},{"key":"1964_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-024-01042-3","author":"B Chen","year":"2024","unstructured":"Chen B, Lenck S, Thomas JL, et al. The glymphatic system as a nexus between obesity and neurological diseases. Nat Rev Endocrinol. 2024. https:\/\/doi.org\/10.1038\/s41574-024-01042-3. [published Online First: 20240920].","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"1964_CR44","doi-asserted-by":"publisher","first-page":"158980","DOI":"10.1016\/j.bbalip.2021.158980","volume":"1866","author":"AB Chai","year":"2021","unstructured":"Chai AB, Lam HHJ, Kockx M, et al. Apolipoprotein E isoform-dependent effects on the processing of alzheimer\u2019s amyloid-beta. Biochim Biophys Acta Mol Cell Biol Lipids. 2021;1866(9):158980. https:\/\/doi.org\/10.1016\/j.bbalip.2021.158980. [published Online First: 20210524].","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"1","key":"1964_CR45","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3233\/JAD-231131","volume":"99","author":"M Kim","year":"2024","unstructured":"Kim M, Song YS, Han K, et al. Impaired glymphatic flow on diffusion tensor MRI as a marker of neurodegeneration in alzheimer\u2019s disease: correlation with Gray matter volume loss and cognitive decline independent of cerebral amyloid deposition. J Alzheimers Dis. 2024;99(1):279\u201390. https:\/\/doi.org\/10.3233\/JAD-231131.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1964_CR46","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/jmri.28892","volume":"59","author":"S Matsushita","year":"2024","unstructured":"Matsushita S, Tatekawa H, Ueda D, et al. The association of metabolic brain MRI, amyloid PET, and clinical factors: A study of alzheimer\u2019s disease and normal controls from the open access series of imaging studies dataset. J Magn Reson Imaging. 2024;59(4):1341\u201348. https:\/\/doi.org\/10.1002\/jmri.28892. [published Online First: 20230709].","journal-title":"J Magn Reson Imaging"},{"key":"1964_CR47","doi-asserted-by":"publisher","first-page":"1221667","DOI":"10.3389\/fnagi.2023.1221667","volume":"15","author":"CJ Park","year":"2023","unstructured":"Park CJ, Kim SY, Kim JH, et al. Evaluation of glymphatic system activity using diffusion tensor image analysis along the perivascular space and amyloid PET in older adults with objectively normal cognition: a preliminary study. Front Aging Neurosci. 2023;15:1221667. https:\/\/doi.org\/10.3389\/fnagi.2023.1221667. [published Online First: 20230727].","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"1964_CR48","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s00702-010-0433-4","volume":"117","author":"CY Lee","year":"2010","unstructured":"Lee CY, Landreth GE. The role of microglia in amyloid clearance from the AD brain. J Neural Transm (Vienna). 2010;117(8):949\u201360. https:\/\/doi.org\/10.1007\/s00702-010-0433-4. [published Online First: 20100615].","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"1964_CR49","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/j.1471-4159.2004.02385.x","volume":"89","author":"BV Zlokovic","year":"2004","unstructured":"Zlokovic BV. Clearing amyloid through the blood-brain barrier. J Neurochem. 2004;89(4):807\u201311. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02385.x.","journal-title":"J Neurochem"},{"issue":"147","key":"1964_CR50","doi-asserted-by":"publisher","first-page":"147ra11","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med. 2012;4(147):147ra11. https:\/\/doi.org\/10.1126\/scitranslmed.3003748.","journal-title":"Sci Transl Med"},{"issue":"12","key":"1964_CR51","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1097\/RLU.0000000000005457","volume":"49","author":"H Jang","year":"2024","unstructured":"Jang H, Chun MY, Yun J, et al. Distinct cognitive trajectories according to amyloid positivity in Non-Alzheimer disease dementias. Clin Nucl Med. 2024;49(12):1073\u201378. https:\/\/doi.org\/10.1097\/RLU.0000000000005457. [published Online First: 20241010].","journal-title":"Clin Nucl Med"},{"issue":"2","key":"1964_CR52","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00234-023-03270-2","volume":"66","author":"G Ringstad","year":"2024","unstructured":"Ringstad G. Glymphatic imaging: a critical look at the DTI-ALPS index. Neuroradiology. 2024;66(2):157\u201360. https:\/\/doi.org\/10.1007\/s00234-023-03270-2. [published Online First: 20240110].","journal-title":"Neuroradiology"},{"issue":"8","key":"1964_CR53","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/head.14607","volume":"63","author":"R Ornello","year":"2023","unstructured":"Ornello R, Bruno F, Frattale I, et al. White matter hyperintensities in migraine are not mediated by a dysfunction of the glymphatic system-A diffusion tensor imaging magnetic resonance imaging study. Headache. 2023;63(8):1128\u201334. https:\/\/doi.org\/10.1111\/head.14607. [published Online First: 20230818].","journal-title":"Headache"}],"container-title":["Alzheimer's Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-01964-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-01964-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-01964-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:48:43Z","timestamp":1774615723000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-01964-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1964"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-01964-2","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional review board of Samsung Medical Center (No. 2021-02-135) approved this study. All participants provided informed consent to participate in the study, and the data were collected in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Henrik Zetterberg has served at scientific advisory boards and\/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has delivered lectures in symposia sponsored by Alzecure, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work).Kaj Blennow has served as a consultant and on advisory boards for Abbvie, AC Immune, ALZPath, AriBio, BioArctic, Biogen, Eisai, Lilly, Moleac Pte. Ltd, Novartis, Ono Pharma, Prothena, Roche Diagnostics, and Siemens Healthineers; has served on data monitoring committees for Julius Clinical and Novartis; has delivered lectures, produced educational materials, and participated in educational programs for AC Immune, Biogen, Celdara Medical, Eisai and Roche Diagnostics; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, outside the work presented in this paper.Kaj Blennow has served as a consultant and on advisory boards for Abbvie, AC Immune, ALZPath, AriBio, BioArctic, Biogen, Eisai, Lilly, Moleac Pte. Ltd, Novartis, Ono Pharma, Prothena, Roche Diagnostics, and Siemens Healthineers; has served on data monitoring committees for Julius Clinical and Novartis; has delivered lectures, produced educational materials, and participated in educational programs for AC Immune, Biogen, Celdara Medical, Eisai and Roche Diagnostics; and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program, outside the work presented in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}